Home Diagnostics (Fort Lauderdale, Florida) and Nipro (Osaka, Japan) have agreed to merge in a two-step acquisition in which Nipro will acquire all outstanding shares of Home Diagnostics' common stock for about $215 million, or $11.50 a share. (Medical Device Daly) Read More